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Abstract
Background: It is known that amino acid oxidation is increased in tumor-bearing rat muscles and
that leucine is an important ketogenic amino acid that provides energy to the skeletal muscle.
Methods: To evaluate the effects of a leucine supplemented diet on the intestinal absorption
alterations produced by Walker 256, growing pregnant rats were distributed into six groups. Three
pregnant groups received a normal protein diet (18% protein): pregnant (N), tumor-bearing (WN),
pair-fed rats (Np). Three other pregnant groups were fed a diet supplemented with 3% leucine
(15% protein plus 3% leucine): leucine (L), tumor-bearing (WL) and pair-fed with leucine (Lp). Non
pregnant rats (C), which received a normal protein diet, were used as a control group. After 20
days, the animals were submitted to intestinal perfusion to measure leucine, methionine and
glucose absorption.
Results: Tumor-bearing pregnant rats showed impairment in food intake, body weight gain and
muscle protein content, which were less accentuated in WL than in WN rats. These metabolic
changes led to reduction in both fetal and tumor development. Leucine absorption slightly
increased in WN group. In spite of having a significant decrease in leucine and methionine
absorption compared to L, the WL group has shown a higher absorption rate of methionine than
WN group, probably due to the ingestion of the leucine supplemented diet inducing this amino acid
uptake. Glucose absorption was reduced in both tumor-bearing groups.
Conclusions: Leucine supplementation during pregnancy in tumor-bearing rats promoted high
leucine absorption, increasing the availability of the amino acid for neoplasic cells and, mainly, for
fetus and host utilization. This may have contributed to the better preservation of body weight gain,
food intake and muscle protein observed in the supplemented rats in relation to the non-
supplemented ones.
Background
Cachexia is a debilitating state and still poorly understood
syndrome of progressive body weight loss present in
many types of cancer. It is characterized by host involun-
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tary weight loss, anorexia and metabolic alterations [1].
The anorexia-cachexia syndrome is a complex metabolic
and behavioral alteration correlated with poor outcome
and compromised quality of life, leading to death [2,3].
Loss of protein is a major factor in the short survival time
of patients with cachexia and may also contribute to the
immunologic abnormalities [2]. Despite the controversy
about the underlying molecular mechanism of cancer
cachexia, the growing tumor has a considerable demand
for essential amino acids and glucose. The tumor daily nu-
trient needs can increase considerately, especially for leu-
cine [4]. As a result of the demand for leucine there is an
amino acid flux from muscle to the tumor associated with
muscular wastage in the host [4].
Muscle wasting may be due to increased protein catabo-
lism, decreased protein synthesis, or a combination of the
two [2]. Smith and Tisdale [5] demonstrated that serum
from cachectic animals was able to increase protein degra-
dation in isolated gastrocnemius muscle, while serum
from mice bearing MAC13 adenocarcinoma, which is not
associated to cachexia, did not increase protein break-
down.
Branched-chain amino acids (BCAA: leucine, isoleucine
and valine) are essential nutrients for both humans and
animals, making up to 40% of the animal daily require-
ments of indispensable amino acids for humans [6], leu-
cine alone representing 8% of body protein in human [7].
In the study of the mechanism that leads to protein waste,
particular interest has been given to the metabolism of
BCAA [8]. The carbon skeletons arising from transamina-
tion of BCAA provide the major source of metabolic fuel
for skeletal muscle. Argiles and Lopez-Soriano [9] have
shown that during cancer, the BCCA plasma levels were
often increased and their turnover rates altered. It has
been previously demonstrated that in vivo leucine oxida-
tion to CO2 is enhanced in tumor-bearing animal [9–11]
and associated to an increased amino acid turnover.
Experiments studying reciprocal influence between cancer
and pregnancy still remain controvertial indicating that,
in some cases, pregnancy has a protective mechanism
against tumor [12] or that there is an increase in fetal re-
sorption incidence and a decrease in fetal weight [13,14].
In our previous studies, it has been shown that a leucine
supplemented diet could prevent, in part, the high cell ni-
trogen wastage (expressed by non-collagen nitrogen) in
pregnant tumor-bearing rats [15].
Amino acids absorption can occur by co-transport system
and facilitated transport systems through cellular path-
ways. The intestinal amino acids transport capacity is re-
lated to the animal age and depends on the microvilli and
the number of carrier on the brush border [16]. The deter-
mination of nutrients or amino acids absorption in cer-
tain pathologies is an important condition to assure the
best dietary program to be given in these cases. Further-
more, this is an important issue in the study of cancer,
since altered intestinal absorption may alter blood chem-
istry and contribute to anorexia genesis. To investigate the
effects of a leucine supplemented diet on leucine, methio-
nine and glucose intestinal absorption in the presence of
Walker 256 tumor growth was the main purpose of the
study reported here.
Methods
Animals and diets
Young female Wistar rats (45 days old, N = 60) were ob-
tained from the animal facilities of University of Campi-
nas, São Paulo, Brazil. The females rats were placed with
adults males (90–100 days old, 4 females: 1 male) in col-
lective cages during one night (12 hours), in agreement
with harem methodology [17]. The first day of pregnancy
was determined following detection of sperm in vaginal
smear.
All animals were kept in metabolic cages under normal
conditions (22+2°C, 12/12 h light/dark cycle) with free
access to water and food during 20 days.
The semi purified control diet contained 18% protein,
63% carbohydrate, 7% fat, and 5% fibers – AIN-93G [18].
High leucine diet contained 15% protein added 3% L-leu-
cine and same amount carbohydrate, fat and fibers per-
centage as the control diet.
Groups of rats studied
The female rats were distributed into 7 groups: four
groups were fed with semi-purified control diet: non-preg-
nant, C; pregnant, N; pregnant tumor-bearing rat, WN;
pregnant pair-fed group, Np, receiving the same amount
of food ingested by tumor-bearing group WN. Three other
pregnant groups were fed with semi-purified leucine sup-
plemented diet: pregnant, L; pregnant tumor-bearing, WL;
and pregnant pair-fed rat receiving leucine supplemented
diet in the same amount ingested by WL group, Lp.
Tumor implantation
Groups WN and WL were subcutaneously implanted with
Walker 256 tumor cell suspension (approx. 0,25 ×  106 in
0,5 mL of saline) in the right flank of the rats. These preg-
nant groups were injected with tumor cells immediately
after the detection of the pregnancy. The groups without
tumor were injected with 0,5 mL 0,9%(w.v.) NaCl with-
out anesthesia.BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/7
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All experiments were commenced between 8:00 and
10:00 am, and followed during 20 days after tumor im-
plantation.
General UKCCR (1988, United Kingdom Coordinating
Committee on Cancer Research) for animal welfare were
followed (Ethical Committee for Animal Research CEEA
and COBEA, Brazil, no. 034-2).
Experimental proceedings
Food intake and body weight were measured every two
days. Tumor weight was calculated from 3 orthogonal lin-
ear measurements using the weight dimension curves
[15].
After 20 days all experimental groups were submitted to
continuing intestinal perfusion, as described by Gomes-
Marcondes et al [19]. The intestinal perfusate fluid sam-
ples were taken to measure leucine, methionine and glu-
cose content after flux perfused solution containing 138,7
µmol/L glucose, or 167,5 µmol/L DL-methionine or
190,5 µmol/L L-leucine; polyethylene glycol (PEG, 4000
mo. Wt) was added to perfused solution as a tracer in nu-
trients uptake studies. The flow rate was 0,5 to 1,0 mL/
min at 37°C, pH 7,0, during 60 min.
The animals were killed after Nembutal hyper dose fol-
lowed by cervical dislocation. Arterial blood samples were
collected to determine glucose, total protein and, albumin
and gastrocnemius muscle samples were weighted and de-
termined the total protein content.
Biochemical determinations
Intestinal perfusate solution and blood glucose were de-
termined by colorimetric method, Trinder [19]. Methio-
nine and leucine perfused solution were measured
following the spectrophotometric methods described by
McCarthy & Sulivan [20] and Rosen [21] respectively. To-
tal protein content was analyzed using colorimetric meth-
od [22].
Statistical analysis
The Kruskal-Wallis one way analysis [23] assessed statisti-
cal differences, using the GraphPad Prism, v 3.00 for Win-
dows 98. The comparisons among groups were
considered statistically significant when the P value was
below 5% level.
Results
Effect of Walker 256 tumor-bearing on body weight, food 
intake and fetal weight
In this study, changes in body and tumor weight were lon-
gitudinally monitored. These data are show in Table 1. In
both pregnant groups, the tumor growth promoted a
sharp decrease in food intake; there was a 58% decrease in
WN compared to N groups, and this decrease was less in-
tense in WL group (50%). Since sharp decrease in food in-
take has been demonstrated in several studies with tumor-
bearing organisms [2,24], the same restriction in food in-
take was imposed to pair-fed groups in the present study.
The body weight gain was significantly reduced in WN
and WL groups compared to their respective control
groups (50% in WN and 42% in WL group). In pair-fed
groups the body weight gain was less impaired compared
to tumor-bearing, around 42% in Np and 38% in Lp.
Table 1: Body weight gain (total body weight on 20th day), food intake, tumor weight/carcass weight, fetal weight of the groups studied.
Body weight gain (%) Food intake (%) Tumor weight/carcass weight (%) Fetal weight (g)
C 30,21 ± 0,27 98,77 ± 4,55
N 45,02 ± 1,32 a 95,75 ± 4,85 3,73 ± 0,13
WN 22,83 ± 0,53 b 40,01 ± 3,56 ab 7,81 ± 0,27 1,61 ± 0,22 b
Np 26,01 ± 1,07 b 2,98 ± 0,34
L 43,19 ± 1,30 a 82,40 ± 8,64 3,45 ± 0,16
WL 24,87 ± 0,61 b 41,29 ± 3,63 ab 7,46 ± 0,33 1,15 ± 0,16 b
Lp 26,78 ± 0,44 b 2,77 ± 0,44
Body weight gain was determined from the rate final body weight gain in relation to initial body weight gain (%). Food intake was expressed as a per-
centage of initial and final food intake (%) Data are reported as means ± SE from 10 animals per group. Groups: control (C); pregnant control (N); 
pregnant tumor-bearing (WN); pregnant control pair-fed to tumor-bearing groups (Np); pregnant control receiving a leucine supplemented diet (L), 
pregnant tumor-bearing receiving a leucine supplemented diet (WL) and pregnant control leucine pair-fed group (Lp). a p < 0,05 compared to con-
trol group (C); b p < 0,05 N vs WN and L vs WL.BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/7
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The same tumor weight was observed in both pregnant tu-
mor-bearing groups. The tumor/carcass weight ratio was
around 7% in both groups.
Fetal weight reduction (57% and 66%, respectively) was
observed in WN and WL rats compared to pregnant rats.
In pair-fed groups, the fetal weight decrease was not as in-
tense as in tumor-bearing groups (around 20% in the
both groups).
Effects of Walker 256 tumor-bearing on circulating param-
eters
Blood glucose, total protein and albumin data are shown
in Table 2.
Blood glucose decreased in pregnant groups, with and
without tumor, in relation to non-pregnant group and
this decrease was especially pronounced in WN groups.
The leucine supplemented diet groups did not show alter-
ations in blood glucose compared to non-pregnant group;
but their values were significantly higher when compared
to N, WN and Np groups, around 26%.
Despite of similar serum total protein values, serum albu-
min was decreased in both tumor-bearing groups com-
pared to respective non tumor-bearing groups (N and L,
Table 2).
Effects of Walker 256 carcinoma on gastrocnemius muscle 
weight and protein
Tumor growth caused a pronounced decrease in muscle
weight and protein content in WN and WL groups (Figure
1). Analyzing the leucine supplemented diet groups, al-
though WL groups presented decrease in muscle protein
content in comparison to L group, the values were slightly
higher than in WN group.
Intestinal Absorption during Walker 256 tumor growth
Glucose, methionine and leucine absorption data are
shown in Figure 2. The pregnant state caused a significant
increase in glucose absorption in relation to non-pregnant
state independently of the diet treatment. This increase
was around two fold in both N and L groups (Figure 2A).
Tumor growth promoted significant decrease in glucose
absorption, of 50% in WN and 30% in WL groups. Both
pair-fed groups also presented a decrease in glucose ab-
sorption (42% in Np and non-significant 25% decrease in
Lp).
Table 2: Glucose, total protein and albumin serum of the groups 
studied.
Glucose serum 
(nmol/L-1)
Serum total protein 
(g/dL)
Serum albumin 
(g/dL)
C 5,35 ± 0,15 7,86 ± 0,50 2,30 ± 0,29
N 4,23 ± 0,21 a 6,47 ± 0,49 2,81 ± 0,31
WN 3,56 ± 0,15 ac 5,06 ± 0,32 2,20 ± 0,23c
Np 4,17 ± 0,21 a 5,82 ± 0,23 2,70 ± 0,33
L5 , 3 4   ± 0,21 b 5,90 ± 0,48 2,92 ± 0,28
WL 4,90 ± 0,18 b 4,72 ± 0,24 2,28 ± 0,32 c
Lp 5,26 ± 0,11 b 5,59 ± 0,26 3,14 ± 0,51
Data are reported as means ± SE from 10 animals per group. Groups: 
control (C); pregnant control (N); pregnant tumor-bearing (WN); 
pregnant control pair-fed to tumor-bearing groups (Np); pregnant 
control receiving a leucine supplemented diet (L), pregnant tumor-
bearing receiving a leucine supplemented diet (WL) and pregnant con-
trol leucine pair-fed group (Lp). a p < 0,05 compared to control group 
(C); b p < 0,05 comparison among L, WL and Lp groups to N, WN 
and Np, respectively, c p < 0,05 N vs WN and L vs WL.
Figure 1
Changes in gastrocnemius muscle weight (A) and protein
content (B) in virgin and pregnant groups. C, virgin control
group; N pregnant group; WN pregnant tumor-bearing
group; Np pregnant pair-fed group; leucine supplemented
diet groups: L pregnant group; WL pregnant tumor-bearing
and Lp pregnant pair-fed group. Data are means ± SE. a p <
0.05 vs control group (C), differences were determined using
two-way ANOVA followed by Dun's test.
CPW P p LW L L p
0.75
1.00
1.25
1.50
a a a a
A
M
u
s
c
l
e
 
W
e
i
g
h
t
 
(
g
)
C PW P p LW L L p
1.5
2.0
2.5
3.0
a
a a
B
M
u
s
c
l
e
 
P
r
o
t
e
i
n
 
(
µ
g
.
µ
L
-
1
)BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/7
Page 5 of 8
(page number not for citation purposes)
Methionine absorption (Figure 2B) was slightly increased
in N, but it was 5 fold higher in L group compared to non-
pregnant group. Tumor-growth induced decrease in food
intake reduced methionine absorption in WN (20%) and
WL group (30%). Similar decrease in this amino acid ab-
sorption was observed in both pair-fed groups.
In contrast, leucine absorption was not increased in the N
group. On the other hand, in pregnant groups which re-
ceived the leucine supplemented diet the absorption rate
was 1.5 fold higher than non-pregnant group.
Although amino acid absorption is controlled by carrier
transport, which can be increased or unchanged by food
deprivation, in tumor-bearing group WN the leucine ab-
sorption was higher compared to non-pregnant and preg-
nant group, suggesting increased nutrient offer to provide
the neoplasic cells proliferation. On the other hand, the
leucine supplemented diet group implanted with Walker
256 tumor presented a decrease in leucine absorption
rate, differently from the pattern showed by WN group.
Discussion
This study demonstrates that the tumor growth produces
some host alterations in pregnant rats, which can be atten-
uated by feeding leucine supplemented diet. In the
present experiments we observed reduction in some pa-
rameters in WL group, such as food intake, body weight
gain, muscle protein content, which were less pronounced
than in WN group (Table 1 and Figure 1).
Reduction in food intake is frequently observed in ani-
mals and patients with cancer and the mechanism in-
volved in the genesis of this process still remains
unknown. The tumor -bearing state is associated with a
decrease in the host insulin: glucagon ratio. Increased glu-
cagon levels can lead to anorexia, as well as increased he-
patic gluconeogenesis and utilisation of gluconeogenic
amino acids at the expense of protein synthesis, leading to
a negative energy balance [25]. In a recent study, decrease
on food intake was observed in Walker tumor -bearing
rats associated to highly decrease in carcass weight
[13,14].
Anorexia is always associated with a pronounced reduc-
tion in body weight gain, in spite of the fact that many
studies have demonstrated that cachexia is a much more
complex process than this simple association. Here in this
study a significant reduction in body weight was observed
in association with decrease in food intake, but these al-
terations were less pronounced in pair-fed groups than in
tumor  bearing groups. Depletion of lean body mass in
cancer cachexia is a major factor responsible for the re-
duced survival time of cancer patients [2]. Both reduced
rates of protein synthesis and increased rates of protein
degradation have been observed in biopsies of skeletal
muscle from cachetic-cancer patients. While muscle-pro-
tein synthesis is depressed, syntheses of secretory proteins,
such as acute-phase reactants by the liver are actually in-
creased, so that there may be no change in total body-pro-
tein synthesis. However, in cancer patients muscle-protein
synthesis only accounted for 8% of total body synthesis
versus 53% for healthy control subjects.
Loss of skeletal-muscle mass in both cancer patients and
an experimental model of cachexia in the mouse has been
shown to correlate with the presence in the serum of bio-
activity capable of inducing protein degradation in isolat-
ed skeletal muscle. Tisdale and his group [2] have found a
glicoprotein, named proteolysis-inducing factor (PIF),
which can promote proteolysis in skeletal muscle of ca-
Figure 2
Changes in glucose (A), methionine (B) and leucine (C) intes-
tinal absorption rates in virgin and pregnant groups. C, virgin
control group; N pregnant group; WN pregnant tumor-bear-
ing group; Np pregnant pair-fed group; leucine supplemented
diet groups: L pregnant group; WL pregnant tumor-bearing
and Lp pregnant pair-fed group. Data are means ± SE. a p <
0.05 vs control group (C); b p < 0.05 comparison N vs WN,
Np, and L VS WL; c p < 0.05 comparison normoprotein diet
vs excess diet.
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chetic tumor  and in non tumor -bearing animals. Our re-
sults showed decrease in muscle weight and protein
content in tumor  bearing rats, especially in the WN
group. These results suggest that probably the leucine sup-
plemented diet can improve the protein synthesis process
or inhibit the degradation mechanism in tumor  bearing
host.
Positive effects of leucine ingestion have been observed in
tissues in catabolic states. McNurlan et al. [26] have inves-
tigated the effect of leucine on protein synthesis in starva-
tion and protein depletion, and suggested that both states
were characterised by loss of body nitrogen and low rates
of tissue protein synthesis. Under these conditions, Li &
Jefferson [27] demonstrated that leucine stimulates pro-
tein synthesis in perfused skeletal muscle. Branched-chain
amino acids (BCAA; leucine, isoleucine, and valine) have
long been recognised as having a clear inhibitory action
on proteolysis in skeletal muscle [27]. Leucine has been
shown to stimulate incorporation of amino acids into
skeletal and cardiac muscle protein [28] and further to in-
hibit protein degradation in liver [29,30] and skeletal
muscle [28]. In vivo studies in rats failed to demonstrate
any effects of leucine on protein synthesis, but in humans,
a mixture of amino acids was reported to stimulate pro-
tein synthesis [26].
Studies with human subjects indicate that the nitrogen
balance is improved in response to BCAA administration
in conditions in which a negative nitrogen balance exists
(e.g., starvation, surgery, acute hepatic failure, and cancer)
[35,32]. Schaur et al. [33] found that dietary administra-
tion of BCAA (leucine and isoleucine) to tumor -bearing
rats caused a limited increase in survival time and decrease
in tumor  growth. Moreover, it has been shown that insu-
lin effects on muscle protein synthesis in vivo are en-
hanced by BCAA infusion [34]. These results support the
hypothesis that BCAA may give important signals in con-
trolling muscle protein turnover.
The results presented here clearly show that leucine is able
to attenuate the muscle proteolysis in tumor-bearing rats.
This effect was expressed in body weight gain, food intake
and muscle protein content. An elegant experiment, done
by Busquets et al. [35] showed that leucine can influence
gene expression for the different proteolytic system ubiq-
uitin, inducing a significant decrease in the expression of
the ubiquitin genes. Furthermore, the presence of the ami-
no acid also caused a decrease in the C8 subunit of the
proteasome. It has to be pointed out that the muscles did
not show any significant change that could affect the ATP-
requiring ubiquitin system in either ATP or phosphocrea-
tine [35].
Normally the processes of growth and metabolism in the
mammalian foetus are supported by a constant uptake of
oxygen, glucose, lactate, and amino acids across the um-
bilical circulation [36]. If the availability of these sub-
strates to the foetus is limited, foetal growth decreases. It
is widely assumed that, once the chorioplacenta is func-
tional amino acid nutrition occurs by the direct placental
transfers of free amino acids from the maternal to the foe-
tal blood stream [37].
Intestinal sugar and amino acid transports are regulated
independently. Inhibition of glucose absorption by high
concentrations of certain amino acids has also been noted
in mammalian cells in culture and in vitro [38,39]. Intes-
tinal amino acid transport is regulated in a complex way,
such as the amino acid transporters are regulated semi-in-
dependently of each other, depending of the uptake of
amino acids which move via different transporters re-
spond differently to the same dietary amino acid [40] or
to dietary levels of protein or protein hydrolysates
[38,39]. These factors may have contributed to the genesis
of the pattern observed for the intestine in the present
study.
Although we observed differences in amino acid uptake
related to leucine excess diet, we observed no such differ-
ences in D-glucose uptake, except in the pregnant groups.
The effects of tumor growth in reducing glucose and me-
thionine absorption rate were evident. On the other hand,
leucine absorption was increased in the tumor  bearing
groups. Conversely, exchanging one dietary sugar for an-
other has specific effects on sugar uptake but not on ami-
no acid uptake [38]. Simultaneous reciprocal changes in
dietary protein and carbohydrate levels affect sugar uptake
and amino acid uptake in opposite directions. Thus intes-
tinal sugar uptake appears to be regulated by dietary sug-
ars or carbohydrates, amino acid uptake by dietary amino
acids or proteins.
A priori, dietary supplementation by different amino ac-
ids might have led to different rates of amino acid trans-
port through some non-specific mechanism, such as
differences in intestinal mucosal mass or architecture or
energy supply or Na+ gradient [38]. Although previous
studies have showed that there was a reduction on the ra-
tio gut mass/ protein content in groups which were sub-
mitted to tumor implant or food restriction decreasing
nutrient intestinal absorption [14], in the present study,
this ratio can not be related to leucine absorption in preg-
nant tumor bearing rats. The decrease in glucose intestinal
absorption was due to reduction in the food intake; as glu-
cose absorption is up-regulated and depends on its carrier
and the pregnant groups (P and L) were adapted to a non-
specific regulation of carriers which can be accompanied
by mucosal hyperplasia. The W and WL group showed de-BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/7
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crease in glucose and methionine absorption compared to
respective groups (P and L). However, analysing leucine
absorption these tumor bearing groups showed changes
in methionine absorption which can not be related to re-
duction in rat mass/ protein gut, but probably to other ef-
fects. These facts might explain why methionine
absorption was significantly increased in leucine supple-
mented diet group (L, WL and Lp, Figure 2). In addition,
Hirst [41] reviewed the amino acid absorptive mecha-
nisms and reported that during nutritional manipulations
there are carrier adaptations, which could have accounted
for the differences found in the tumor -bearing groups of
the present study. Thus the amino acid transport altera-
tions related to diet supplementation with different ami-
no acids might involve specific effects on transporters,
especially when associated with neoplastic growth. The
mechanisms involved in the physiological impact of leu-
cine on the effects of tumor  growth remains to be further
elucidated.
Although, leucine did not appear to protect fetal growth
impairment when a tumor is present, the major effect of
leucine supplementation during pregnancy in tumor-
bearing rats was to prevent experimental hypoglycaemia
and promote high leucine absorption, maybe increasing
the availability of the amino acid for neoplasic cells and
host utilization. This may have contributed to the better
preservation of body weight gain, food intake and muscle
protein observed in the supplemented rats in relation to
the non supplemented ones.
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